Combating Rising Antimicrobial Resistance: Advancing Public Health Preparedness, Antibiotics, & Innovation

Join the Duke-Margolis Center for Health Policy for an important discussion on combating rising antimicrobial resistance (AMR) in the context of U.S. public health preparedness, support for novel antibiotics, global AMR policy leadership, and emerging multi-sector innovation.

Duke-Margolis Director Dr. Mark McClellan will moderate conversations with the Honorable Senator Michael Bennet, former FDA Commissioner Dr. Scott Gottlieb, Senior Global Health Officer at the Department of Health and Human Services Lynn Filpi, CDC Senior Advisor for Antibiotic Resistance Michael Craig, as well as colleagues from the Partnership to Fight Infectious Disease (PFID), the AMR Action Fund, CARB-X, and Civica Rx.

Rising antimicrobial resistance remains a top global public health threat and efforts to support novel antibiotic development and availability are more critical and timely than ever. As the ongoing pandemic centers national and global conversations around actions to prevent and combat future infectious disease threats, the time to take action against AMR is now. 

Duke-Margolis publishes policy research on promising approaches and recommendations to combat AMR and rising drug-resistant infections. See the publications linked below to learn more.